Jasper Therapeutics Inc
Biotechnology
Healthcare
JSPR
15.02 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.52
52 week high
24.73
high
2.56
52 week low
0.00
low
2.38
growth
-89.95 %
previous Close
2.54
P/E ratio
-1
market cap
45.52 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-26.72 M
-25.81 %
eps
-1.74 %
-23.40 %
eps surprise
-31.18 %
net profit margin
-2672300000.00 %
0.00 %
operating incoming
-27.08 M
-24.19 %
net change in cash
-9.29 M
59.33 %
cash on hand
39.51 M
-19.04 %
cost of revenue
0.00 %
top top